RT Journal Article
SR Electronic
T1 Early Spread of SARS-Cov-2 in the Icelandic Population
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.26.20044446
DO 10.1101/2020.03.26.20044446
A1 Gudbjartsson, Daniel F
A1 Helgason, Agnar
A1 Jonsson, Hakon
A1 Magnusson, Olafur T
A1 Melsted, Pall
A1 Norddahl, Gudmundur L
A1 Saemundsdottir, Jona
A1 Sigurdsson, Asgeir
A1 Sulem, Patrick
A1 Agustsdottir, Arna B
A1 Eiriksdottir, Berglind
A1 Fridriksdottir, Run
A1 Gardarsdottir, Elisabet E
A1 Georgsson, Gudmundur
A1 Gretarsdottir, Olafia S
A1 Gudmundsson, Kjartan R
A1 Gunnarsdottir, Thora R
A1 Gylfason, Arnaldur
A1 Holm, Hilma
A1 Jensson, Brynjar O
A1 Jonasdottir, Aslaug
A1 Jonsson, Frosti
A1 Josefsdottir, Kamilla S
A1 Kristjansson, Thordur
A1 Magnusdottir, Droplaug N
A1 Roux, Louise le
A1 Sigmundsdottir, Gudrun
A1 Sveinbjornsson, Gardar
A1 Sveinsdottir, Kristin E
A1 Sveinsdottir, Maney
A1 Thorarensen, Emil A
A1 Thorbjornsson, Bjarni
A1 Löve, Arthur
A1 Masson, Gisli
A1 Jonsdottir, Ingileif
A1 Moller, Alma
A1 Gudnason, Thorolfur
A1 Kristinsson, Karl G
A1 Thorsteinsdottir, Unnur
A1 Stefansson, Kari
YR 2020
UL http://medrxiv.org/content/early/2020/03/31/2020.03.26.20044446.abstract
AB BACKGROUND Limited data exist on how SARS-CoV-2 enters and spreads in the general population.METHODS We used two strategies for SARS-CoV-2 testing: targeted testing of high-risk individuals (n=4,551) and a population screening (n=5,502). We sequenced SARS-CoV-2 from 340 individuals.RESULTS On March 22 2020, 528 had tested positive for SARS-CoV-2 in the targeted testing (11.6%) and 50 in the population screening (0.9%); approximately 0.2% of the Icelandic population. Large fractions of positives had travelled outside Iceland (38.4% and 34.0%). Fewer under 10 years old were positive than those older: 2.8% vs. 12.3% for targeted testing (P=1.6e-9) and 0.0% vs. 1.0% for population screening (P=0.031). Fewer females were positive in the targeted testing than males (9.5% vs. 14.6%, P=6.8e-9). SARS-CoV-2 came from eight clades, seven A clades and one B clade. The clade composition differed between the testing groups and changed with time. In the early targeted testing, 65.0% of clades were A2a1 and A2a2 derived from Italian and Austrian skiing areas, but in the later targeted testing went down to 30.6% and were overtaken by A1a and A2a, the most common clades in the population screening.CONCLUSION SARS-CoV-2 has spread widely in Iceland outside of the high-risk groups. Several strains cause these infections and their relative contribution changed rapidly. Children and females are less vulnerable than adults and males. To contain the pandemic we must increase the scope of the testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll sequenced virus genomes have been deposited into GISAID.